Human cytomegalovirus (HCMV) is a herpesvirus that infects~ 60% of adults in developed
countries and more than 90% in developing countries. Usually, it is controlled by a vigorous …

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a new zoonotic human
viral pathogen endemic to the Middle East. 1–3 It was identified in 2012 in a lung sample of …

Importance Valganciclovir for 200 days is standard care for cytomegalovirus (CMV)
prophylaxis in high-risk CMV-seronegative kidney transplant recipients who receive an …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

Background Cytomegalovirus (CMV) infection remains a common complication after
allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the …

Cytomegalovirus (CMV) infection and disease are important causes of morbidity and
mortality in transplant recipients. For the purpose of developing consistent reporting of CMV …

The prevention, diagnosis, and management of infectious disease in transplantation are
major contributors to improved outcomes in organ transplantation. The risk of serious …

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …

Cytomegalovirus (CMV) is a ubiquitousherpes virus that infects the majority of humans (1).
The seroprevalence rates of CMV ranges from 30–97%(2, 3). Primary infection manifests as …